Total assets increased 80.4%
Total assets changed +80.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +80.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating margin changed +5026364 basis points from the comparable as-filed period.
Operating cash flow changed +27.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -25.0% from the comparable as-filed period.
Gross margin changed +18302 basis points from the comparable as-filed period.
Stock-based compensation changed +52.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +33.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Short-term borrowings changed -84.3% from the comparable as-filed period.
SBC / revenue changed -127177 basis points from the comparable as-filed period.
Research & development changed -32.4% from the comparable as-filed period.
Revenue changed +1031.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Working capital changed +21.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +50.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +4885457 basis points from the comparable as-filed period.
Working capital / assets changed +2819 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed +3379.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
R&D / revenue changed -13911 basis points from the comparable as-filed period.
Current liabilities changed -11.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +3101.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.